If you’re comparing MS care in Pennsylvania, you’ll find options across the state from Pittsburgh to Hershey and the Lehigh Valley. Consider factors like center focus, proximity, and provider experience when choosing a center such as Allegheny Multiple Sclerosis Treatment Center, Geisinger Neuroscience Institute Multiple Sclerosis Clinic, or Penn State Milton S. Hershey Comp MS Center to find the best fit for your needs.
15 MS treatment centers26 active clinical trialsTop centers in Pittsburgh, Hershey, Lehigh Valley3 providers with Medicare prescribing data
Center types in Pennsylvania
Dedicated MS Practice (5)
Academic MS Center (5)
Regional Neurology Group (3)
Boutique MS Practice (1)
Community Hospital Program (1)
Filter by type:
Centers with Most Active Trials in Pennsylvania
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
Largest Care Teams in Pennsylvania
1. UPMC Multiple Sclerosis Care Center2 providers
MS Care by City
Active MS clinical trials in Pennsylvania
See all 31 MS trials in Pennsylvania →ActivePhase 3
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Novartis Pharmaceuticals
Philadelphia
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Hershey
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Philadelphia
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Pittsburgh · Reading
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Philadelphia · Willow Grove
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Philadelphia
ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Willow Grove
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Bethlehem








